[1. Peltonen S, Kallionpää RA, Peltonen J. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas. Exp Dermatol 2017;26(7):645-648.10.1111/exd.1321227622733]Search in Google Scholar
[2. Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009; 61(1): 1-16.10.1016/j.jaad.2008.12.051271654619539839]Search in Google Scholar
[3. von Recklinghausen FD. Über die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Festschrift für Rudolf Virchow. Berlin, 1882.]Search in Google Scholar
[4. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81-8.10.1136/jmg.2006.045906259806317105749]Search in Google Scholar
[5. Surchev JK, Nachev S, Todorova LP, et al. Optic Nerve Glioma in Two Sisters with Family History of Neurofibromatosis Type 1. J Neurol Surg A Cent Eur Neurosurg. 2018;79(3):268-272.10.1055/s-0037-160886929294511]Search in Google Scholar
[6. Vlenterie M, Flucke U, Hofbauer LC, et al. Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. Am J Med. 2013;126(2):174-80.10.1016/j.amjmed.2012.07.02223331445]Search in Google Scholar
[7. Allaway RJ, Gosline SJ, La Rosa S, et al. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Br J Cancer 2018;118(12):1539-1548.10.1038/s41416-018-0073-2600843929695767]Search in Google Scholar
[8. Packer RJ, Fisher MJ, Cutter G, et al. Neurofibromatosis Clinical Trial Consortium. J Child Neurol 2018;33(1):82-91.10.1177/088307381773919629246097]Search in Google Scholar
[9. Widemann BC, Acosta MT, Ammoun S, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A 2014; 164(3):563-78.10.1002/ajmg.a.36312415021224443315]Search in Google Scholar
[10. Walker JA, Upadhyaya M. Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets 2018;22(5):419-437.10.1080/14728222.2018.1465931701775229667529]Search in Google Scholar
[11. Rad E, Tee AR. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Semin Cell Dev Biol 2016; 52:39-46.10.1016/j.semcdb.2016.02.00726860753]Search in Google Scholar
[12. Hanemann CO, Blakeley JO, Nunes FP, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016;87(7 Suppl 1): S40-8.10.1212/WNL.0000000000002932557836027527649]Search in Google Scholar